{"id":"NCT00284856","sponsor":"Organon and Co","briefTitle":"Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel-Group 6-Month Study to Evaluate the Efficacy and Safety of Oral Montelukast Sodium, Fluticasone Propionate and Placebo in Patients With Chronic Asthma Who Smoke Cigarettes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-05","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2006-02-01","resultsPosted":"2011-05-03","lastUpdate":"2024-05-10"},"enrollment":1640,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"montelukast sodium","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]},{"type":"DRUG","name":"Comparator: fluticasone","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"},{"label":"3","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter study to evaluate the efficacy and safety of MK0476 versus placebo in participants with chronic asthma who actively smoke cigarettes.","primaryOutcome":{"measure":"Percentage of Asthma-control Days Over the 6-month Treatment Period","timeFrame":"6 months","effectByArm":[{"arm":"Montelukast","deltaMin":50.7,"sd":38.19},{"arm":"Fluticasone","deltaMin":53.3,"sd":39.06},{"arm":"Placebo","deltaMin":43.84,"sd":38.08}],"pValues":[{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["23380218"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":347},"commonTop":["Asthma","Nasopharyngitis"]}}